Transfer of Iron from enterocyte to plasma is inhibited by?
The question asks what inhibits this transfer. I remember that hepcidin is a key hormone in iron metabolism. Hepcidin binds to ferroportin, causing its internalization and degradation, which reduces iron export. So if hepcidin is present, less iron is released into the plasma. That makes hepcidin the inhibitor of this transfer.
Now, looking at the options that were supposed to be provided but are missing, the correct answer is likely hepcidin. The other options might include things like vitamin C, which enhances iron absorption, or other factors like transferrin itself, which isn't an inhibitor. Also, maybe ferroportin is listed, but since it's the transporter, it's not the inhibitor.
For the explanation, I need to structure it according to the user's guidelines. The core concept is about iron homeostasis and the role of hepcidin. The correct answer explanation should detail how hepcidin inhibits ferroportin. The wrong options would be things that don't inhibit this process. The clinical pearl is that hepcidin is the main regulator, and its dysregulation can lead to conditions like anemia or hemochromatosis.
I need to make sure each section is concise, uses the right terminology, and stays within the character limit. Also, check that all parts of the user's requested structure are included without markdown headers. Let me put this all together now.
**Core Concept**
Iron absorption involves uptake into enterocytes via DMT1 and export into plasma via ferroportin. Hepcidin, a liver-derived hormone, regulates systemic iron homeostasis by inhibiting ferroportin activity, preventing iron release from enterocytes and macrophages.
**Why the Correct Answer is Right**
Hepcidin binds to ferroportin, triggering its internalization and degradation. This blocks iron export from enterocytes to plasma, reducing serum iron levels. In states of iron overload or inflammation, hepcidin production increases, effectively "trapping" iron in enterocytes and macrophages. This mechanism is central to diagnosing anemia of chronic disease (high hepcidin) vs. iron-deficiency anemia (low hepcidin).
**Why Each Wrong Option is Incorrect**
**Option A:** Vitamin C enhances non-heme iron absorption by reducing ferric (Fe³⁺) to ferrous (Fe²⁺) iron, facilitating DMT1 uptake. It does not inhibit ferroportin.
**Option B:** Transferrin binds plasma iron but does not regulate its release from enterocytes. Its role is transport, not inhibition.
**Option C:** Ferroportin is the *transporter* of iron out of enterocytes. Its inhibition (not presence) causes reduced iron export.
**Clinical Pearl /